Biostage, Inc. Joins the Stock Day Podcast to Discuss Their Pending FDA Application

The Stock Day Podcast welcomed Jim McGorry of Biostage, Inc. (BSTG) (“the Company”), a biotechnology startup developing bioengineered organ implants based on its Cellspan technology that combines a proprietary biocompatible scaffold with a patient's own stem cells to create bioengineered organ implants. McGorry is the Company CEO and director, and was joined by Stock Day host Everett Jolly.